Page last updated: 2024-12-06

n,n-diethylhydroxylamine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

N,N-Diethylhydroxylamine (DEHA) is a colorless liquid with a characteristic amine-like odor. It is a versatile reagent employed in organic synthesis, particularly as a reducing agent and a source of free radicals. DEHA is synthesized by the reaction of diethylamine with hydrogen peroxide. It exhibits a range of biological effects, including antioxidant and anti-inflammatory properties. DEHA has been investigated as a potential therapeutic agent for various conditions, including cancer and neurodegenerative diseases. Its biological activity stems from its ability to scavenge reactive oxygen species (ROS), which are implicated in cellular damage. Furthermore, DEHA is used as an intermediate in the production of pharmaceuticals, agrochemicals, and other fine chemicals. The compound's unique properties, including its reducing capacity, free radical generation, and potential for therapeutic applications, contribute to its ongoing research and development.'

N,N-diethylhydroxylamine: RN given refers to parent cpd [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID19463
CHEMBL ID3184786
MeSH IDM0103422

Synonyms (48)

Synonym
diethylhydroxylamine
brn 1731349
einecs 223-055-4
n-hydroxydiethylamine
n,n-diethylhydroxyamine
hydroxylamine, n,n-diethyl-
n,n-diethylhydroxylamine
ccris 964
ai3-28026
n,n-diethylhydroxylamine, >=98%
D1339
3710-84-7
ethanamine, n-ethyl-n-hydroxy-
n-ethyl-n-hydroxyethanamine
fvcoiaysjzgecg-uhfffaoysa-
inchi=1/c4h11no/c1-3-5(6)4-2/h6h,3-4h2,1-2h3
D1178
NCGC00248584-01
dtxcid107543
dtxsid2027543 ,
tox21_200264
NCGC00257818-01
cas-3710-84-7
314i05edvh ,
hsdb 6819
4-04-00-03304 (beilstein handbook reference)
unii-314i05edvh
ec 223-055-4
FT-0629477
AKOS015903887
n,n-diethylhydroxylamine [hsdb]
hydroxydiethylamine
pennstop 1866
(c2h5)2noh
1-[ethyl(hydroxy)amino]ethane #
CHEMBL3184786
J-523240
n,n-dethylhydroxylamne
mfcd00002126
diethyl hydroxylamine
Q3334148
n,n-diethyl-hydroxylamine
AMY25658
EN300-136085
n,n-diethylhydroxylamine (ca. 85% in water, ca. 8.6mol/l)
n,n-diethyl hydroxylamine
CS-W013744
E83007

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
" One hundred thirty-seven animals survived the dosing period."( The effect of diethylhydroxylamine on the incidence of tumors induced by benzo(a)pyrene in the mouse.
Heicklen, J; Massaro, EJ; Miller, GD; Wilson, T, 1984
)
0.27
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Pathways (1)

PathwayProteinsCompounds
triethylamine degradation016

Protein Targets (6)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
RAR-related orphan receptor gammaMus musculus (house mouse)Potency67.05790.006038.004119,952.5996AID1159521
GLI family zinc finger 3Homo sapiens (human)Potency22.05340.000714.592883.7951AID1259368; AID1259369; AID1259392
pregnane X nuclear receptorHomo sapiens (human)Potency59.76550.005428.02631,258.9301AID1346982
aryl hydrocarbon receptorHomo sapiens (human)Potency50.36970.000723.06741,258.9301AID743085; AID743122
thyrotropin-releasing hormone receptorHomo sapiens (human)Potency35.56510.154917.870243.6557AID1346877; AID1346891
histone deacetylase 9 isoform 3Homo sapiens (human)Potency26.69630.037617.082361.1927AID1259364
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (17)

TimeframeStudies, This Drug (%)All Drugs %
pre-19907 (41.18)18.7374
1990's4 (23.53)18.2507
2000's2 (11.76)29.6817
2010's2 (11.76)24.3611
2020's2 (11.76)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.73

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.73 (24.57)
Research Supply Index2.94 (2.92)
Research Growth Index4.67 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.73)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (5.56%)6.00%
Case Studies1 (5.56%)4.05%
Observational0 (0.00%)0.25%
Other16 (88.89%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]